异动解读 | Hims & Hers前三季业绩亮眼新品规划利好盘中股价大涨5.62%

异动解读11-06

远程医疗公司Hims & Hers Health Inc.(HIMS)今日盘中股价大涨5.62%,引发了市场的广泛关注。公司前三季度出色的业绩表现以及新品规划成为推动股价上涨的主要因素。

财报数据显示,Hims & Hers前三季度净利润达1亿美元,较去年同期由亏转盈,营收同比大增58.9%,毛利率高达80.7%。这一优异成绩凸显了该公司在远程医疗行业的领先地位和竞争优势,市场对此反响热烈。

除了出色的财务表现外,Hims & Hers还计划在2025年推出诺公司减肥疗法liraglutide的非专利版本,这将为公司带来新的增长动力。分析师预计,公司的强劲盈利表现和新品上市将持续推动其股价上涨。投资者看好公司前景,当日大幅买盘入场。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1198362140?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-06 22:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198362140","market":"hk","top_or_hot":-1,"title":"异动解读 | Hims & Hers前三季业绩亮眼 新品规划利好 盘中股价大涨5.62%","media":"异动解读","content":"<p>远程医疗公司Hims & Hers Health Inc.(HIMS)今日盘中股价大涨5.62%,引发了市场的广泛关注。公司前三季度出色的业绩表现以及新品规划成为推动股价上涨的主要因素。</p>\n\n<p>财报数据显示,Hims & Hers前三季度净利润达1亿美元,较去年同期由亏转盈,营收同比大增58.9%,毛利率高达80.7%。这一优异成绩凸显了该公司在远程医疗行业的领先地位和竞争优势,市场对此反响热烈。</p>\n\n<p>除了出色的财务表现外,Hims & Hers还计划在2025年推出诺公司减肥疗法liraglutide的非专利版本,这将为公司带来新的增长动力。分析师预计,公司的强劲盈利表现和新品上市将持续推动其股价上涨。投资者看好公司前景,当日大幅买盘入场。</p>","source":"ai_movement_cn","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读 | Hims & Hers前三季业绩亮眼 新品规划利好 盘中股价大涨5.62%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读 | Hims & Hers前三季业绩亮眼 新品规划利好 盘中股价大涨5.62%\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-06 22:38 北京时间&nbsp;&nbsp;&nbsp;<strong>异动解读</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>远程医疗公司Hims & Hers Health Inc.(HIMS)今日盘中股价大涨5.62%,引发了市场的广泛关注。公司前三季度出色的业绩表现以及新品规划成为推动股价上涨的主要因素。\n财报数据显示,Hims & Hers前三季度净利润达1亿美元,较去年同期由亏转盈,营收同比大增58.9%,毛利率高达80.7%。这一优异成绩凸显了该公司在远程医疗行业的领先地位和竞争优势,市场对此反响热烈。\n除了...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1198362140","we_media_id":"1092702339","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198362140","pubTimestamp":1730903905,"sourceInfo":{"source_id":"ai_movement_cn","name":"异动解读"},"weMediaInfo":{"media_name":"异动解读","introduction":"个股异动一手消息解读","home_visible":1,"id":"1092702339","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"远程医疗公司Hims & Hers Health Inc.今日盘中股价大涨5.62%,引发了市场的广泛关注。公司前三季度出色的业绩表现以及新品规划成为推动股价上涨的主要因素。财报数据显示,Hims & Hers前三季度净利润达1亿美元,较去年同期由亏转盈,营收同比大增58.9%,毛利率高达80.7%。除了出色的财务表现外,Hims & Hers还计划在2025年推出诺公司减肥疗法liraglutide的非专利版本,这将为公司带来新的增长动力。投资者看好公司前景,当日大幅买盘入场。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"Interpretation of changes: Hims & Hers' outstanding performance in the first three quarters is good, and its new product planning is good. The intraday stock price rose 5.62%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"远程医疗公司Hims & Hers Health Inc.(HIMS)今日盘中股价大涨5.62%,引发了市场的广泛关注。公司前三季度出色的业绩表现以及新品规划成为推动股价上涨的主要因素。\n财报数据显示,Hims & Hers前三季度净利润达1亿美元,较去年同期由亏转盈,营收同比大增58.9%,毛利率高达80.7%。这一优异成绩凸显了该公司在远程医疗行业的领先地位和竞争优势,市场对此反响热烈。\n除了出色的财务表现外,Hims & Hers还计划在2025年推出诺公司减肥疗法liraglutide的非专利版本,这将为公司带来新的增长动力。分析师预计,公司的强劲盈利表现和新品上市将持续推动其股价上涨。投资者看好公司前景,当日大幅买盘入场。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1198362140"}

异动解读 | Hims & Hers前三季业绩亮眼 新品规划利好 盘中股价大涨5.62%

精彩评论

异动解读 | Hims & Hers前三季业绩亮眼新品规划利好盘中股价大涨5.62%